SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-295134
Filing Date
2021-10-08
Accepted
2021-10-08 11:24:55
Documents
14
Period of Report
2021-10-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d241111d8k.htm   iXBRL 8-K 28742
2 EX-99.1 d241111dex991.htm EX-99.1 21842
6 GRAPHIC g241111g1008070054540.jpg GRAPHIC 3726
  Complete submission text file 0001193125-21-295134.txt   184291

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20211008.xsd EX-101.SCH 2904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20211008_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20211008_pre.xml EX-101.PRE 10961
7 EXTRACTED XBRL INSTANCE DOCUMENT d241111d8k_htm.xml XML 3231
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 211314365
SIC: 2834 Pharmaceutical Preparations